title: EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.
abstract: Epidermal growth factor module-containing mucin-like hormone receptor-3 (EMR-3) is a G-protein coupled receptor with unknown ligand and cellular function. Upregulation of EMR-3 in glioblastoma (GBM) multiforme is associated with poor survival. We investigated the expression patterns and functional significance of EMR-3 in GBM using immunohistochemistry, western blot, reverse transcription PCR, and small interfering RNA knockdown in proliferation and invasion assays. EMR-3 is variably expressed in primary human GBM tissues and cell lines. Knocking down EMR-3 has no impact on cellular proliferation, but decreases cellular invasion by greater than 3-fold. EMR-3 is a potential mediator of cellular invasion in GBM. Given the poor survival associated with high levels of EMR-3 expression in glioma patients, our results provide impetus to explore EMR-3 as a potential therapeutic target.
authors.affiliation: Department of Neurological Surgery, Division of Neuropathology, University of California at San Francisco, San Francisco, California 94143, USA.
authors.forename: Ari J
authors.initials: AJ
authors.lastname: Kane
authors.forename: Michael E
authors.initials: ME
authors.lastname: Sughrue
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Rutkowski
authors.forename: Joanna J
authors.initials: JJ
authors.lastname: Phillips
authors.forename: Andrew T
authors.initials: AT
authors.lastname: Parsa
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics; D001932:Brain Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D003937:Diagnosis, Differential; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D005909:Glioblastoma / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D009361:Neoplasm Invasiveness / Q000235:genetics / Q000473:pathology*; D010641:Phenotype; D034622:RNA Interference / Q000502:physiology; D043562:Receptors, G-Protein-Coupled / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D018000:Receptors, Peptide / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D015996:Survival Rate / Q000639:trends
chemical_list: C431147:ADGRE3 protein, human; D014408:Biomarkers, Tumor; D043562:Receptors, G-Protein-Coupled; D018000:Receptors, Peptide
references.citation: J Neurosurg. 2005 Apr;102(4):622-8
references.pmid: 15871503
references.citation: FASEB J. 2008 Mar;22(3):741-51
references.pmid: 17928360
references.citation: Biochem Biophys Res Commun. 2007 Feb 2;353(1):133-8
references.pmid: 17174274
references.citation: Trends Biochem Sci. 2008 Oct;33(10):491-500
references.pmid: 18789697
references.citation: Blood. 2003 Oct 15;102(8):2916-24
references.pmid: 12829604
references.citation: J Biol Chem. 2001 Jun 1;276(22):18863-70
references.pmid: 11279179
references.citation: J Neurosurg. 2001 Aug;95(2):190-8
references.pmid: 11780887
references.citation: J Clin Neurosci. 2010 Dec;17(12):1573-7
references.pmid: 20829050
references.citation: J Leukoc Biol. 2007 Feb;81(2):440-8
references.pmid: 17108056
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):108-19
references.pmid: 15668483